.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
McKesson
US Department of Justice
Argus Health
Express Scripts
Johnson and Johnson
QuintilesIMS
Citi
US Army
Cerilliant

Generated: December 14, 2017

DrugPatentWatch Database Preview

Powder Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for POWDER PHARMS, and what generic alternatives to POWDER PHARMS drugs are available?

POWDER PHARMS has one approved drug.

There are four US patents protecting POWDER PHARMS drugs.

There are twenty-one patent family members on POWDER PHARMS drugs in twelve countries.

Summary for Powder Pharms

International Patents:21
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007RXNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Powder Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Powder Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,044,546Particle cassettes and processes therefor► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Powder Pharms Drugs

Country Document Number Estimated Expiration
Argentina066425► Subscribe
United Kingdom0708758► Subscribe
Germany69729634► Subscribe
World Intellectual Property Organization (WIPO)2015130961► Subscribe
United Kingdom9605690► Subscribe
Australia2015222937► Subscribe
European Patent Office3110404► Subscribe
China106163500► Subscribe
European Patent Office0892649► Subscribe
Taiwan200916139► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Citi
Chinese Patent Office
Daiichi Sankyo
Mallinckrodt
Cipla
Healthtrust
Fish and Richardson
Argus Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot